"The market share for the [Tagrisso-chemo] regimen continues to expand, and the recently announced positive overall survival results reinforce Tagrisso's position as the frontline standard of care in ...

Neuroendocrine Carcinoma Treatment Market Poised to Exceed USD 4.3 Billion by 2034, Propelled by Precision Medicine, Immunotherapy Breakthroughs The global neuroendocrine carcinoma (NEC) treatment ...

Sports Medicine Market Poised for Significant Growth, Projecting USD2.3 Billion by 2035, Driven by Surging Injury Rates, Regenerative Therapies The global sports medicine market is on a robust growth ...

SBC Medical endeavors to capture this high-value market segment, including through integration of JUN CLINIC's proven model and its team of highly skilled professionals—validated by their role ...

Buyers are keeping to the sidelines of the California market, bringing down prices and pushing inventory up.

According to Coherent Market Insights (CMI), the global traditional medicine market size is expected to grow at a CAGR of 7.7%, expanding from USD 213.81 Bn in 2025 to USD 359.37 Bn by 2032.

Atsena and the FDA discussed expanding the LIGHTHOUSE trial and the regulatory path to approval for ATSN-201 during a recent regenerative medicine advanced therapy (RMAT) meeting. The FDA earlier this ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin drug strategy.

EXCLUSIVE: Josh Segarra (Abbott Elementary, Scream 6) has joined the cast of Fox ‘s medical comedy Best Medicine, starring opposite Josh Charles and Abigail Spencer. The series, based on the ...

Purdue launches cutting-edge graduate degree in radiopharmaceutical manufacturing in Indianapolis through industry partnership New master’s program emphasizes manufacturing expertise to meet growing ...